Company intelligence / Profile preview

3DMorphic

Sydney/Matraville, New South Wales, Australia3dmorphic.com ↗

Ownership: Private
Development stage: Other

Overview

Clinical results from testimonials indicate significant improvements in pain relief, mobility, and quality of life for patients receiving personalized spinal implants. A landmark clinical trial funded by MTPConnect aims to provide further evidence that these patient-specific devices deliver better outcomes than traditional off-the-shelf alternatives.

Therapeutic areas: OtherNeurology
Modalities: Device (specifically, patient-specific spinal implants and orthopaedic surgical devices)
Industry: Implantable Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed. Received grant funding from MTPConnect for a landmark clinical trial.

Beyond the preview

Go deeper on 3DMorphic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3DMorphic.

Explore the full profile